Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Rimegepant 75 mg is Effective for the Acute Treatment of Migraine Regardless of Attack Frequency: Results From 3 Phase 3 Trials
Headache
P6 - Poster Session 6 (12:00 PM-1:00 PM)
7-005

The objective of this study was to evaluate the influence of migraine attack frequency on the efficacy of rimegepant.

Acute treatment is used by almost everyone with migraine, regardless of attack frequency. Rimegepant is a small molecule CGRP receptor antagonist with demonstrated efficacy and safety in the acute treatment of migraine.